Search Results - "Rommelfanger, K S"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Norepinephrine: The redheaded stepchild of Parkinson's disease by Rommelfanger, K.S., Weinshenker, D.

    Published in Biochemical pharmacology (15-07-2007)
    “…Parkinson's disease (PD) affects approximately 1% of the world's aging population. Despite its prevalence and rigorous research in both humans and animal…”
    Get full text
    Journal Article
  2. 2

    Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice by Rommelfanger, K.S, Edwards, G.L, Freeman, K.G, Liles, L.C, Miller, G.W, Weinshenker, D

    “…Although Parkinson's disease (PD) is characterized primarily by loss of nigrostriatal dopaminergic neurons, there is a concomitant loss of norepinephrine (NE)…”
    Get full text
    Journal Article
  3. 3

    Light and electron microscopic localization of alpha-1 adrenergic receptor immunoreactivity in the rat striatum and ventral midbrain by Rommelfanger, K.S, Mitrano, D.A, Smith, Y, Weinshenker, D

    Published in Neuroscience (18-02-2009)
    “…Abstract Electrophysiological and pharmacological studies have demonstrated that alpha-1 adrenergic receptor (α1AR) activation facilitates dopamine (DA)…”
    Get full text
    Journal Article
  4. 4

    The role of placebo in the diagnosis and treatment of functional neurologic disorders by Rommelfanger, K S

    Published in Handbook of clinical neurology (2016)
    “…Placebo therapy can produce meaningful, clinical relief for a variety of conditions. While placebos are not without their ethically fraught history, they…”
    Get more information
    Journal Article
  5. 5

    Guidelines for the ethical use of neuroimages in medical testimony: report of a multidisciplinary consensus conference by Meltzer, C C, Sze, G, Rommelfanger, K S, Kinlaw, K, Banja, J D, Wolpe, P R

    Published in AJNR. American journal of neuroradiology (01-04-2014)
    “…With rapid advances in neuroimaging technology, there is growing concern over potential misuse of neuroradiologic imaging data in legal matters. On December 7…”
    Get full text
    Journal Article Conference Proceeding
  6. 6

    Reduced MPTP toxicity in noradrenaline transporter knockout mice by Rommelfanger, Karen S., Weinshenker, David, Miller, Gary W.

    Published in Journal of neurochemistry (01-12-2004)
    “…The noradrenergic neurons of the locus coeruleus (LC) are damaged in Parkinson's disease (PD). Neurotoxin ablation of the LC noradrenergic neurons has been…”
    Get full text
    Journal Article